Showing results (391-400 of 416) with videos related to
Sort By:
Pageof 42
Journal of Clinical Medicine|November 27, 2019
Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate CancerJuan M Jiménez-Vacas, Enrique Gómez-Gómez, Antonio J Montero-Hidalgo, et al.Oncogene|August 9, 2018
Vav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanismsL Francisco Lorenzo-Martín, Carmen Citterio, Mauricio Menacho-Márquez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2024
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer StudyMiguel Martín, Elgene Lim, Mariana Chavez-MacGregor, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|September 11, 2022
Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genesJuan M Jiménez-Vacas, Antonio J Montero-Hidalgo, Enrique Gómez-Gómez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2019
Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10Jame Abraham, Albert J Montero, Rachel C Jankowitz, et al.Phytotherapy Research : PTR|June 26, 2024
Anti-inflammatory and anti-hyperalgesic effects induced by an aqueous aged black garlic extract in rodent models of ulcerative colitis and colitis-associated visceral painMaria Loreta Libero, Elena Lucarini, Lucia Recinella, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast CancerAvia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini, et al.Cancer|May 10, 2012
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trialAllyson J Ocean, Kenneth L Pennington, Michael J Guarino, et al.Breast Cancer Research : BCR|April 22, 2024
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancerSamuel A Jacobs, Ying Wang, Jame Abraham, et al.Molecular Therapy. Oncology|January 6, 2025
Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic targetAntonio J Montero-Hidalgo, Enrique Gómez-Gómez, Manuel Galán-Cañete, et al.Pageof 42